Differentiation of Human Pluripotent Stem Cells into Kidney Cell Lineages
人多能干细胞分化为肾细胞谱系
基本信息
- 批准号:8995260
- 负责人:
- 金额:$ 40.42万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2015
- 资助国家:美国
- 起止时间:2015-09-23 至 2017-08-31
- 项目状态:已结题
- 来源:
- 关键词:3-DimensionalAddressAdverse effectsArtificial KidneyArtsCell Culture SystemCell Culture TechniquesCell Differentiation processCell LineageCellsCommunitiesComplexComputer softwareCoupledDataDevelopmentDevicesDisease modelDistalDuctal EpitheliumEmbryoEnd stage renal failureEpithelial CellsEventExcretory functionFutureGenerationsGrowthHumanImmune responseIn VitroIonsKidneyKidney DiseasesLiquid substanceLogicMedicalMesenchymalMesodermMetanephric DiverticulumMethodsModalityModelingMolecularNephronsNeuronsOrganPancreasPatientsPatternPhasePluripotent Stem CellsPopulationProceduresProcessPropertyProtocols documentationRegenerative MedicineRenal functionResearchResourcesRoboticsSeriesSignal PathwayStagingStructureTechnologyTestingTransplantationUrineWaterWorkbasecell typeclinical applicationclinically relevantdesigndiabeticembryonic stem cellhuman embryonic stem cellin vivoinduced pluripotent stem cellinnovationinsightkidney cellkidney epithelial cellnephrogenesisnovelnovel therapeuticsprogenitorpublic health relevanceresearch studyself organizationsolutethree dimensional structuretoolwasting
项目摘要
DESCRIPTION (provided by applicant): The kidney is a vital organ required for waste excretion as well as water and solute reabsorption. Its functionality relies on a range of highly specialized cells that are arranged into nephrons, the functional units of the kidney. While we understand many of the properties of the different renal cell types, we lack effective methods for their differentiation from pluripotent precursors. This single-objective collaborative project is directly addressing this question focusing on establishing the basic principles for developing pure populations of terminal differentiated kidney cells. In the UH2 phase of the project we will establish optimal differentiation conditions to obtain pure renal cell subtypes derived from human embryonic stem cells. We will do this by leveraging locally available liquid handling robotic capabilities combined with deep analytics. This innovative platform was specifically designed for directed differentiation, and will be utilized for defining optimal kidney cell differentiation/maturation conditions, starting with the current state of the art differentiation protocols. In the UH3 phase we will then test the potential of these kidney cells for future use in
clinical applications. In particular, we will focus on their potential for the development of artifcial kidneys. We will examine one of the key functions of kidney epithelial cells, the ability to reabsorb ions and other solute. We, we will also assess whether the differentiated cell can be used to generate nephrons in- vitro or re-populate decellularized kidneys. Together, these aims will provide very valuable information and resources for the scientific community that will aid in developing novel therapeutic advances such as artificial kidney benefitting a wide range of patients with kidney diseases.
描述(申请人提供):肾脏是排泄废物以及水和溶质重吸收所必需的重要器官。它的功能依赖于一系列高度专业化的细胞,这些细胞排列成肾单位,即肾脏的功能单位。虽然我们了解不同类型肾脏细胞的许多特性,但我们缺乏有效的方法将它们与多能前体细胞区分开来。这个单一目标的合作项目直接解决了这个问题,重点是建立发展终末分化的肾脏细胞纯群体的基本原则。在该项目的UH2阶段,我们将建立从人类胚胎干细胞获得纯肾细胞亚型的最佳分化条件。我们将利用当地可用的液体处理机器人能力并结合深度分析来实现这一点。这个创新的平台是专门为定向分化而设计的,将从当前最先进的分化方案开始,用于确定最佳的肾脏细胞分化/成熟条件。在UH3阶段,我们将测试这些肾脏细胞未来用于
临床应用。特别是,我们将重点关注它们在人工肾脏发展方面的潜力。我们将研究肾上皮细胞的关键功能之一,即重新吸收离子和其他溶质的能力。我们,我们还将评估分化的细胞是否可以用来在体外产生肾单位,或者重新填充脱细胞的肾脏。总而言之,这些目标将为科学界提供非常有价值的信息和资源,帮助开发新的治疗进展,如人工肾,使广泛的肾脏疾病患者受益。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
JAN JENSEN其他文献
JAN JENSEN的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('JAN JENSEN', 18)}}的其他基金
Defining the Pancreatic Progenitor Mesenchymal Niche
定义胰腺祖细胞间充质生态位
- 批准号:
8577465 - 财政年份:2013
- 资助金额:
$ 40.42万 - 项目类别:
Defining the Pancreatic Progenitor Mesenchymal Niche
定义胰腺祖细胞间充质生态位
- 批准号:
8719991 - 财政年份:2013
- 资助金额:
$ 40.42万 - 项目类别:
A multidisciplinary approach towards cell therapy for Diabetes
糖尿病细胞疗法的多学科方法
- 批准号:
7861399 - 财政年份:2010
- 资助金额:
$ 40.42万 - 项目类别:
Molecular mechanism of FGF10 signaling in pancreatic development
FGF10信号在胰腺发育中的分子机制
- 批准号:
8002432 - 财政年份:2005
- 资助金额:
$ 40.42万 - 项目类别:
Molecular mechanism of FGF10 signaling in pancreatic development
FGF10信号在胰腺发育中的分子机制
- 批准号:
7031488 - 财政年份:2005
- 资助金额:
$ 40.42万 - 项目类别:
Molecular mechanism of FGF10 signaling in pancreatic development
FGF10信号在胰腺发育中的分子机制
- 批准号:
7254724 - 财政年份:2005
- 资助金额:
$ 40.42万 - 项目类别:
Molecular mechanism of FGF10 signaling in pancreatic development
FGF10信号在胰腺发育中的分子机制
- 批准号:
7122078 - 财政年份:2005
- 资助金额:
$ 40.42万 - 项目类别:
Molecular mechanism of FGF10 signaling in pancreatic development
FGF10信号在胰腺发育中的分子机制
- 批准号:
7455199 - 财政年份:2005
- 资助金额:
$ 40.42万 - 项目类别:
相似海外基金
Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
- 批准号:
MR/S03398X/2 - 财政年份:2024
- 资助金额:
$ 40.42万 - 项目类别:
Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
- 批准号:
EP/Y001486/1 - 财政年份:2024
- 资助金额:
$ 40.42万 - 项目类别:
Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
- 批准号:
2338423 - 财政年份:2024
- 资助金额:
$ 40.42万 - 项目类别:
Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
- 批准号:
MR/X03657X/1 - 财政年份:2024
- 资助金额:
$ 40.42万 - 项目类别:
Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
- 批准号:
2348066 - 财政年份:2024
- 资助金额:
$ 40.42万 - 项目类别:
Standard Grant
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
- 批准号:
2341402 - 财政年份:2024
- 资助金额:
$ 40.42万 - 项目类别:
Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
- 批准号:
AH/Z505481/1 - 财政年份:2024
- 资助金额:
$ 40.42万 - 项目类别:
Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 40.42万 - 项目类别:
EU-Funded
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 40.42万 - 项目类别:
EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
- 批准号:
AH/Z505341/1 - 财政年份:2024
- 资助金额:
$ 40.42万 - 项目类别:
Research Grant